<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34672897</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>59</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ<sub>1-</sub><sub>40</sub> injection in ovariectomized Alzheimer's disease model rats.</ArticleTitle>
        <Pagination>
          <StartPage>1402</StartPage>
          <EndPage>1414</EndPage>
          <MedlinePgn>1402-1414</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2021.1990353</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Erzhi pills are a classic Chinese medicine prescription, but their effects on Alzheimer's disease (AD) are not clear.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The protective effects of Erzhi pills in AD rats and their potential mechanisms were investigated.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">An AD rat model was established by ovariectomy combined with d-galactose and Aβ<sub>1-40</sub> injection. Rats were randomly divided into five groups: sham-operated, model, oestradiol valerate (0.80 mg/kg), Erzhi pills high-dose (1.50 g/kg), and Erzhi pills low-dose (0.75 g/kg). Learning and memory abilities were evaluated with the Morris water maze test, oestrogen levels with an ELISA kit, and hippocampal neuron morphology and Nissl bodies in the cytoplasm with H&amp;E and Nissl staining. The expression of ERβ, Aβ<sub>1-40</sub>, and p-tau<sup>404</sup> was determined by immunohistochemistry. Nano LC-LTQ-Orbitrap Proteomics determined potential targets and related signalling pathways. Western blotting was used to detect the expression of the related proteins.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Erzhi pills (1.5, 0.75 g/kg) markedly reduced escape latencies on the MWM, increased numbers of platform crossings, numbers of neurons, Nissl bodies, oestrogen levels (100.18, 43.04 pg/mL), and ERβ-positive cells (57.42, 39.83); Aβ<sub>1-40</sub> (18.85, 36.83)- and p-tau<sup>404</sup> (14.42, 29.71)-positive cells were significantly decreased. Proteomics identified more than 100 differentially expressed proteins involved in 48 signalling pathways, five of which are involved in the PI3K/Akt signalling pathway. Western blotting showed decreased expression of GSK3β and Bad, while Akt, PI3K, 14-3-3, Bcl-xl, and Bcl-2 were upregulated.</AbstractText>
          <AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">Erzhi pills may serve as a potential agent for AD therapeutics by improving learning and memory.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Yongyan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Development Department, Shandong Qidu Pharmaceutical Co., Ltd, Zibo, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hou</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Pharmacy Department, The Second People's Hospital of Jingdezhen, Jingdezhen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Maofu</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Chao</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, China Pharmaceutical University, Nanjing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Mengsheng</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Kun</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Cong</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yaohui</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology Department, Jiang Xi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Liping</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C078592">amyloid beta-protein (1-40)</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C477278">erzhi pill</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.1.137</RegistryNumber>
          <NameOfSubstance UI="D058539">Phosphatidylinositol 3-Kinase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>X2RN3Q8DNE</RegistryNumber>
          <NameOfSubstance UI="D005690">Galactose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Organism" UI="C000715067">Kunming mice</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021461" MajorTopicYN="N">Animals, Outbred Strains</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004365" MajorTopicYN="N">Drugs, Chinese Herbal</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005690" MajorTopicYN="N">Galactose</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018782" MajorTopicYN="N">Maze Learning</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010052" MajorTopicYN="N">Ovariectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058539" MajorTopicYN="N">Phosphatidylinositol 3-Kinase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Learning</Keyword>
        <Keyword MajorTopicYN="N">PI3K/Akt signalling pathway</Keyword>
        <Keyword MajorTopicYN="N">memory</Keyword>
        <Keyword MajorTopicYN="N">traditional Chinese medicine</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>21</Day>
          <Hour>20</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34672897</ArticleId>
        <ArticleId IdType="pmc">PMC8547838</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2021.1990353</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bean LA, Ianov L, Foster TC.. 
2014. Estrogen receptors, the hippocampus, and memory. Neuroscientist. 20(5):534–545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4317255</ArticleId>
            <ArticleId IdType="pubmed">24510074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA, De Jager PL.. 
2014. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 82(3):222–229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3902759</ArticleId>
            <ArticleId IdType="pubmed">24336141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai XJ, Huang MY, Zhang L.. 
2011. Research progress on the source and pharmacological effects of Erzhi pills. Chin J Exp Tradi Med Form. 17:272–275.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen YH, Yan B, Guan Y, Liu YQ, Zhou YM, Huang Y, Zhou MF, Huang LP.. 
2019. Effect of Erjing pills on learning and memory abilities of AD rats with kidney Yin deficiency induced by ovariectomy+d-galactose combined with Aβ1-40. Tradi Chin Drug Res Clin Pharmacol. 30:1421–1427.</Citation>
        </Reference>
        <Reference>
          <Citation>Fu LL, Ding H, Han LF, Jia L, Yang WZ, Zhang CX, Hu L, Zuo TT, Gao XM, Guo DA.. 
2019. Simultaneously targeted and untargeted multicomponent characterization of Erzhi pill by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry. J Chromatogr A. 1584:87–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30473109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao HL, Wang DQ, Wang XY, Wang ZG, Wang XM, Wu ZE, Liu H, Ma YY, Niu XH, Li LD.. 
2010. Effect of Erzhi pill (二至丸) on improving cerebral nerve cell apoptosis in aging rats. Chin J Integr Med. 16(6):504–509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21110175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M.
2015. Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Aβ, tau, and α-synuclein. Science. 349(6248):1255555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26250687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong Y, Hua N, Zang X, Huang T, He L.. 
2018. Melatonin ameliorates Aβ1-42-induced Alzheimer’s cognitive deficits in mouse model. J Pharm Pharmacol. 70(1):70–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28994117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao DC, Xiao PG.. 
2014. Network pharmacology: a rosetta stone for traditional Chinese medicine. Drug Dev Res. 75(5):299–312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25160070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hou M, Fu YJ, Liu C, Wei YF, Chen YF, Xie YH, Huang LP.. 
2016. Effects of extraction from raspberry on hippocampus proteomics of mice suffered from ovariectomized induced AD. Chi J Chin Mater Med. 41:2895–2900.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28914035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua X, Lei M, Zhang Y, Ding J, Han Q, Hu G, Xiao M.. 
2007. Long-term d-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer’s disease. Life Sci. 80(20):1897–1905.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17391708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang LP, Yan B, Hou M, Sun MS, He K, Guan Y, Yao LH, Zhou MF.. 
2017. Study on material basis and mechanism of Erzhi Wan prevent Alzheimer’s disease by network pharmacology. Chin J Chin Mater Med. 42:4211–4217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29271163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang LP, Yan B, Hou M, Sun MS, He K, Guan Y, Yao LH, Zhou MF.. 
2018. Effect of Erzhi Wan on hippocampus proteomics of mice of ovariectomized-induced AD. Chin J Exp Tradi Med Form. 24:150–156.</Citation>
        </Reference>
        <Reference>
          <Citation>Ibrahim WW, Safar MM, Khattab MM, Agha AM.. 
2016. 17β-Estradiol augments antidepressant efficacy of escitalopram in ovariectomized rats: neuroprotective and serotonin reuptake transporter modulatory effects. Psychoneuroendocrinology. 74:240–250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27685339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irvine K, Laws KR, Gale TM, Kondel TK.. 
2012. Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis. J Clin Exp Neuropsychol. 34(9):989–998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22913619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, Kang T, Qi B, Kong L, Jiao Y, Cao Y, Zhang J, Yang J.. 
2016. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of d-galactose/AlCl3 inducing rats model of Alzheimer’s disease. J Ethnopharmacol. 179:162–169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26721223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Zhang L, Yang CC.. 
2016. Multi-target strategy and experimental studies of traditional Chinese medicine for Alzheimer’s disease therapy. Curr Top Med Chem. 16(5):537–548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26268330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC.. 
2021. PI3K/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer’s disease and Parkinson’s disease. Front Pharmacol. 12(648636):648636.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8082498</ArticleId>
            <ArticleId IdType="pubmed">33935751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuo FS, Andrade MF, Loyola AM, da Silva SJ, Silva MJB, Cardoso SV, de Faria PR.. 
2018. Pathologic significance of AKT, mTOR, and GSK3β proteins in oral squamous cell carcinoma-affected patients. Virchows Arch. 472(6):983–997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29713826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pair FS, Yacoubian TA.. 
2021. 14-3-3 proteins: novel pharmacological targets in neurodegenerative diseases. Trends Pharmacol Sci. 42(4):226–238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8011313</ArticleId>
            <ArticleId IdType="pubmed">33518287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandey A, Mann M.. 
2000. Proteomics to study genes and genomes. Nature. 405(6788):837–846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10866210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patterson C.
2018. World Alzheimer Report 2018. The state of the art of dementia research: new frontiers. An analysis of prevalence, incidence, cost and trends. London, UK: Alzheimer’s Disease International.</Citation>
        </Reference>
        <Reference>
          <Citation>Paxinos G, Watson C.. 
2005. The rat brain in stereotaxic coordinates. Amsterdam: Elsevier Academic Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Peri A.
2016. Neuroprotective effects of estrogens: the role of cholesterol. J Endocrinol Invest. 39(1):11–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26084445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pike CJ.
2017. Sex and the development of Alzheimer’s disease. J Neurosci Res. 95(1–2):671–680.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5120614</ArticleId>
            <ArticleId IdType="pubmed">27870425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirskanen M, Hiltunen M, Mannermaa A, Helisalmi S, Lehtovirta M, Hänninen T, Soininen H.. 
2005. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer’s disease in women. Eur J Hum Genet. 13(9):1000–1006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15944651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quiroz-Baez R, Ferrera P, Rosendo-Gutierrez R, Morán J, Bermúdez-Rattoni F, Arias C.. 
2011. Caspase-12 activation is involved in amyloid-β protein-induced synaptic toxicity. J Alzheimers Dis. 26(3):467–476.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21694457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sadik G, Tanaka T, Kato K, Yamamori H, Nessa BN, Morihara T, Takeda M.. 
2009. Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem. 108(1):33–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19014373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sayas CL, Ávila J.. 
2021. GSK-3 and Tau: a key duet in Alzheimer’s disease. Cells. 10(4):721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8063930</ArticleId>
            <ArticleId IdType="pubmed">33804962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherwin BB.
2006. Estrogen and cognitive aging in women. Neuroscience. 138(3):1021–1026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16310965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherwin BB.
2009. Estrogen therapy: is time of initiation critical for neuroprotection?
Nat Rev Endocrinol. 5(11):620–627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19844249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimada T, Fournier AE, Yamagata K.. 
2013. Neuroprotective function of 14-3-3 proteins in neurodegeneration. Biomed Res Int. 2013:564534–564511.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3865737</ArticleId>
            <ArticleId IdType="pubmed">24364034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song LB, Xiong HP, Li J, Liao WT, Wang L, Wu JH, Li MF.. 
2011. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin Cancer Res. 17(7):1839–1849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21325072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Souza LC, Filho CB, Goes AT, Fabbro LD, de Gomes MG, Savegnago L, Oliveira MS, Jesse CR.. 
2013. Neuroprotective effect of physical exercise in a mouse model of Alzheimer’s disease induced by β-amyloid1–40 peptide. Neurotox Res. 24(2):148–163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23307759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vorhees CV, Williams MT.. 
2006. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 1(2):848–858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2895266</ArticleId>
            <ArticleId IdType="pubmed">17406317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walton JR.
2012. Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer’s disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis. 2012:1–947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3423924</ArticleId>
            <ArticleId IdType="pubmed">22928148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu JG, Wang YY, Zhang ZL, Yu B.. 
2015. Herbal medicine in the treatment of Alzheimer’s disease. Chin J Integr Med. 21(2):102–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24752473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu XF, Duan LX, Gao XL, Guo ML, Wang DM.. 
2019. Study on preventive and therapeutic effects of Erzhi pills on mice with Parkinson's disease induced by MPTP. Zhongguo Zhong Yao Za Zhi. 44:4219–4224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31872702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang B, Wang Y, Li H, Xiong R, Zhao Z, Chu X, Li Q, Sun S, Chen S.. 
2016. Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer’s disease models. Drug Des Devel Ther. 10:1335–1343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4827895</ArticleId>
            <ArticleId IdType="pubmed">27103787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Y, Zheng HX, Xu Y, Lin N.. 
2017. Research progress in phytoestrogens of traditional Chinese medicine. Chin J Chin Mater Med. 42:3474–3487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29218931</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
